FCF YoY
+35.62%
OCF YoY
+29.41%
Capex YoY
-64.67%
FCF Conversion Δ
+4.5 pp
Free cash flow bridge for AbbVie (ABBV) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $5.48B
FCF bridge breakdown for AbbVie (ABBV) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $15.38B | — |
| Operating Cash Flow | $4.82B | +88.0% |
| Capital Expenditure | $657.00M | +12.0% |
| Free Cash Flow | $20.86B | — |
- Prior Free Cash Flow$15.38B
- Operating Cash Flow$4.82B
- Capital Expenditure$657.00M
- Free Cash Flow$20.86B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement